Market Overview

The Global Predictive & Presymptomatic Testing Market was valued at USD XX million in 2023 and is expected to reach USD XX million by 2031 while growing at a CAGR of 8.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global predictive & presymptomatic testing market growth. Predictive and presymptomatic testing evaluate the likelihood of developing a genetic disorder before symptoms appear, often for individuals with a family history of the condition or heightened risk due to factors like ethnicity or environmental exposure.

Advancements in genetic testing technologies, coupled with the rising prevalence of genetic disorders such as hereditary cancers, neurodegenerative diseases, and cardiovascular conditions, drive the demand for predictive and presymptomatic testing. Nevertheless, market growth faces obstacles due to concerns over cost, affordability, as well as ethical and legal considerations.

Furthermore, the global predictive & presymptomatic testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Condition Analysis

The Global Predictive & Presymptomatic Testing Market is segmented among Breast and Ovarian Cancer, Colorectal Cancer, Alzheimer's Disease, Multiple Endocrine Neoplasia Type, and Haemochromatosis, based on Condition. In 2023, Breast and Ovarian Cancer accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Predictive & Presymptomatic Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories Inc., Quest Diagnostics Inc., Positive Bioscience, Color Genomics, Gene by Gene, Mapmygenome, Myriad Genetics, BioAxis DNA Research Center Private Limited, Direct Laboratory Services LLC, Pathway Genomics Corporation, and Ambry Genetics Corporation.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Predictive & Presymptomatic Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Predictive & Presymptomatic Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Predictive & Presymptomatic Testing Market Segmentation, By Condition

• Global Predictive & Presymptomatic Testing Market Share Analysis, By Condition

• Global Predictive & Presymptomatic Testing Market Growth Analysis, By Condition

• Global Predictive & Presymptomatic Testing Market Trends, By Condition

o Breast and Ovarian Cancer

o Colorectal Cancer

o Alzheimer's Disease

o Multiple Endocrine Neoplasia Type

o Haemochromatosis

6. Global Predictive & Presymptomatic Testing Market Segmentation, By Region

• Global Predictive & Presymptomatic Testing Market Share Analysis, By Region

• Global Predictive & Presymptomatic Testing Market Growth Analysis, By Region

• Global Predictive & Presymptomatic Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• Abbott Laboratories Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Quest Diagnostics Inc.

• Positive Bioscience

• Color Genomics

• Gene by Gene

• Mapmygenome

• Myriad Genetics

• BioAxis DNA Research Center Private Limited

• Direct Laboratory Services LLC

• Pathway Genomics Corporation

• Ambry Genetics Corporation  

*Similar analysis will be provided for each company listed above.